Related Experiment Video

Updated: Jan 13, 2026

Synovial Fluid Analysis to Identify Osteoarthritis
07:51

Synovial Fluid Analysis to Identify Osteoarthritis

Published on: October 20, 2022

6.1K

PAFLAR guidelines for oligoarticular juvenile idiopathic arthritis

Waleed Hassan1, Doaa Mosad Mosa2, Ayodele Faleye3

  • 1Rheumatology and Rehabilitation Department, Benha University, Banha, Egypt.

Clinical Rheumatology
|January 6, 2026
PubMed

Insights

Updated guidelines offer evidence-based treatment options for childhood oligoarticular juvenile idiopathic arthritis (JIA) in Africa. These recommendations emphasize early diagnosis and a multidisciplinary, treat-to-target approach for better patient outcomes.

Area of Science:

  • Pediatric Rheumatology
  • Clinical Practice Guidelines
  • Evidence-Based Medicine

Background:

  • Oligoarticular juvenile idiopathic arthritis (JIA) is a chronic condition affecting children in Africa.
  • There is a need for updated, region-specific recommendations for managing JIA.
  • A treat-to-target approach is crucial for optimizing outcomes in pediatric rheumatology.

Purpose of the Study:

  • To develop evidence-based recommendations for the diagnosis and management of oligoarticular JIA in African children.
  • To provide a range of therapeutic options tailored to the African context.
  • To promote a consistent, multidisciplinary, treat-to-target approach.

Main Methods:

  • A consensus was reached by the Paediatric Society of the African League Against Rheumatism (PAFLAR).
  • The Delphi technique and PICO approach were used to address 15 key questions.
  • A systematic literature review informed a voting process among 22 pediatric rheumatology experts.

Main Results:

  • A consensus was achieved on 15 recommendations covering diagnosis, monitoring, management, and complications of oligoarticular JIA.
  • High levels of agreement (85-95%) were reported among experts.
  • A 100% response rate ensured comprehensive input.

Conclusions:

  • The recommendations facilitate early diagnosis and multidisciplinary management of oligoarticular JIA.
  • These guidelines aim to improve practice consistency among healthcare providers in Africa.
  • Emphasis is placed on JIA-specific characteristics, severity factors, and diverse treatment alternatives.
Abstract

Keywords:
ArthritisGuidelinesJuvenileOligoarticularTreatment

More Related Videos

Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients02:28

Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients

Published on: March 1, 2024

759
Anterior Cruciate Ligament Transection and Synovial Fluid Lavage in a Rodent Model to Study Joint Inflammation and Posttraumatic Osteoarthritis06:28

Anterior Cruciate Ligament Transection and Synovial Fluid Lavage in a Rodent Model to Study Joint Inflammation and Posttraumatic Osteoarthritis

Published on: September 2, 2025

1.1K

Related Concept Videos

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
473
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
192
Development of the Limb Synovial Joints01:07

Development of the Limb Synovial Joints

Joints form during embryonic development in conjunction with the formation and growth of the associated bones. The embryonic tissue that gives rise to all bones, cartilage, and connective tissues of the body is called mesenchyme.
The mesenchymal stem cells differentiate into chondrocytes that form the hyaline cartilage, and later the cartilaginous model of the bone. This model further transforms into a bone. This process is known as endochondral ossification.
During development, the limbs...
2.2K
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
278
Rheumatic Heart Disease IV: Nursing Management01:20

Rheumatic Heart Disease IV: Nursing Management

AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
262
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
480